Document:

EX-10.14

 Exhibit 10.14 

 
 

 
 Eric S. Whitaker 

Piedmont, CA 
 Dear Eric, 

I am pleased to offer you a position with 10x Genomics, Inc. (the “Company”), as General Counsel based in Pleasanton, California. If you
decide to join us, you will receive a monthly salary of $25,000.00, which will be paid semi-monthly in accordance with the Company’s normal payroll procedures. As a full-time employee, you will also be eligible to receive certain employee
benefits including paid time off, holiday pay, and company sponsored medical insurance. This position reports to the CEO, Serge Saxonov, and will interact closely with colleagues in all disciplines of the company. You should note that the Company
may modify job titles, salaries, and benefits from time to time as it deems necessary. 
 In addition, you are eligible to participate in the 2017 annual
bonus plan. You will receive a separate letter detailing your bonus target and terms of the bonus plan. Full time, non-sales employees hired before August 31st of the bonus plan year are eligible to
participate. Employees must be active 10x employees on the date of payment for any bonus to be earned and paid. Any bonus will be paid at the discretion of the Board of Directors. The Company reserves the right to amend or withdraw the bonus, at its
absolute discretion. 
 Subject to the approval of the Company’s Board of Directors, you will be granted an option to purchase 525,000 shares of the
Company’s common stock. The option will be subject to the terms and conditions applicable to options granted under the Company’s 2012 Stock Plan, as described in that plan and the applicable stock option agreement, which you will be
required to sign. You will vest in 25% of the option shares on the 12-month anniversary of your vesting commencement date and 1/48th of the total option
shares will vest in monthly installments thereafter during continuous service, as described in the applicable stock option agreement. The exercise price per 

  

					
		  	7068 Koll Center Parkway, Suite 401, Pleasanton, CA 94566	  	

 

 
  

 
share will be equal to the fair market value per share on the date the option is granted, as determined by the Company’s Board of Directors in good faith compliance with applicable guidance
in order to avoid having the option be treated as deferred compensation under Section 409A of the Internal Revenue Code of 1986, as amended. There is no guarantee that the Internal Revenue Service will agree with this value. You should consult
with your own tax advisor concerning the tax risks associated with accepting an option to purchase the Company’s common stock. 
 The Company is
excited about your joining and looks forward to a beneficial and productive relationship. Nevertheless, you should be aware that your employment with the Company is for no specified period and constitutes
at-will employment. As a result, you are free to resign at any time, for any reason or for no reason. Similarly, the Company is free to conclude its employment relationship with you at any time, with or
without cause, and with or without notice. We request that, in the event of resignation, you give the Company at least two weeks notice. This at-will employment provision may not be modified or amended except
by a written agreement signed by the CEO of the Company and you. 
 We also ask that, if you have not already done so, you disclose to the Company any and
all agreements relating to your prior employment that may affect your eligibility to be employed by the Company or limit the manner in which you may be employed. It is the Company’s understanding that any such agreements will not prevent you
from performing the duties of your position and you represent that such is the case. Moreover, you agree that, during the term of your employment with the Company, you will not engage in any other employment, occupation, consulting, or other
business activity directly related to the business in which the Company is now involved or becomes involved during the term of your employment, nor will you engage in any other activities that conflict with your obligations to the Company.
Similarly, you agree not to bring any third party confidential information to the Company, including that of your former employer, and that in performing your duties for the Company you will not in any way utilize or disclose any such information.

  

					
		  	7068 Koll Center Parkway, Suite 401, Pleasanton, CA 94566	  	

 

 
  

 The Company is offering you employment because of your experience and personal skills, and not due to your
potential or actual knowledge of a former employer or other persons or entity’s confidential information or intellectual property, including customer lists and trade secrets. Should you accept this offer, we do not want you to retain, make use
of, or share any such information with the Company. Likewise, as an employee of the Company, it is likely that you will become knowledgeable about the Company’s confidential and trade secret information relating to operations, products, and
services. To protect the Company’s interests, your acceptance of this offer and commencement of employment with the Company are contingent upon the execution and delivery to the Company of the Company’s
At-Will Employment, Confidential Information, Invention Assignment, and Arbitration Agreement (“Confidentiality Agreement”) prior to or on your Start Date. The Confidentiality Agreement, which
provides for the arbitration of all disputes arising out of your employment, is enclosed for your review, and you understand that you are being offered employment in exchange for the mutual promise to arbitrate disputes described therein. Because
the Confidentiality Agreement is one of the most important documents you will sign in connection with your employment with the Company, we trust you will review it carefully and let us know if you have any questions. 

The Company reserves the right to conduct background investigations and/or reference checks on all of its potential employees. Your job offer, therefore, is
contingent upon a clearance of such a background investigation and/or reference check, if any. 
 For purposes of federal immigration law, you will be
required to provide to the Company documentary evidence of your identity and eligibility for employment in the United States. Such documentation must be provided to us within three (3) business days of your date of hire, or our employment
relationship with you may be terminated. 
 In addition, please find enclosed a copy of the 10x welcome letter to prospective employees. Read it carefully
and let us know if you any questions. 
 To accept the Company’s offer, please sign and date this letter in the space provided below. If you accept our
offer, your first day of employment will be July 6, 2017. This letter, along with any 

  

					
		  	7068 Koll Center Parkway, Suite 401, Pleasanton, CA 94566	  	

 

 
  

 
agreements relating to proprietary rights between you and the Company, set forth the terms of your employment with the Company and supersede any prior representations or agreements including, but
not limited to, any representations made during your recruitment, interviews, or pre-employment negotiations, whether written or oral. This offer of employment will terminate if it is not accepted, signed, and
returned by June 14, 2017. 
 We look forward to your favorable reply and to working with you at 10x. 

 

	
	Sincerely,
	
	/s/ Serge Saxonov
	Serge Saxonov
	CEO

  

					
		  	7068 Koll Center Parkway, Suite 401, Pleasanton, CA 94566	  	

 

 
  

			
	Agreed to and accepted:
		
	Signature:	 	/s/ Eric S. Whitaker

			
		
	Printed Name:	 	Eric S. Whitaker

			
		
	Date:	 	June 12, 2017

 Enclosures 
  

	 	•	 	 At-Will Employment, Confidential Information, Invention Assignment, and
Arbitration Agreement 

  

	 	•	 	 10x welcome letter to prospective employees 

  

					
		  	7068 Koll Center Parkway, Suite 401, Pleasanton, CA 94566	  	

 July 25, 2017 

Eric Whitaker 
 RE: 10x Genomics Annual Bonus Plan 

Dear Eric, 
 At 10x, investing in our employees is essential.
Without everyone’s contribution, our mission could not be a reality. 
 “We build products that deliver the most complete and
actionable genomics data. We believe in elegant solutions that work every time in everyone’s hands.” 
 In 2017 we announced the 10x Genomics
Annual Bonus Plan. This bonus plan expands the 10x total compensation package which includes your base salary, benefits, and equity. 
 You are receiving
this letter because you are eligible to participate in the Annual Bonus Plan. Your target bonus is 16% of your annual base salary. Your individual bonus amount will be determined using a combination of 100% overall company performance and 0%
individual performance. Bonus amounts will be prorated in the first year of employment and for changes in salary or job level. 
 The company funded pool
can range from 0–125% of target depending on our performance against financial goals we set and were approved by the Board of Directors. Bonuses will be determined and paid early next year. Full time,
non-sales employees hired before August 31st, 2017 of the bonus plan year are eligible to participate. This bonus is being paid as an incentive for continued employment, and therefore employees must be active
10x employees on the date of payment for any bonus to be earned and paid. Any bonus will be paid at the discretion of the Board of Directors. The Company reserves the right to interpret, amend, suspend or terminate the bonus plan or any bonus
payments at its absolute discretion. This bonus plan does not constitute an employment contract. Employment at 10x is at-will. 

We look forward to your ongoing support in finishing the year strong. For additional information on the terms of the plan or a copy of the plan guide, please
contact HR. 
 Best regards, 
 The 10x Executive TeamEX-10.15

 Exhibit 10.15 

 
 

 
 Justin McAnear 
 Dear
Justin: 
 I am very pleased to offer you a position with 10x Genomics, Inc. (the “Company”), as Chief Financial Officer based in Pleasanton,
California. The following will outline the terms of your employment: 
 Position: Your start date will be September 28, 2018, or such other date
as may be mutually agreed upon between you and the Company (the “Start Date”). Your title will be Chief Financial Officer (“CFO”), and you will report to the CEO, Serge Saxonov, and will interact closely with colleagues in all
disciplines of the Company. You will have such duties and responsibilities, consistent with your position as CFO, as may from time to time require. You agree to perform your duties faithfully and to the best of your abilities and to devote your full
business efforts and time to the Company. This is a full-time position. While you render services to the Company, you will not engage in any other employment, consulting, or other business activity or occupation (whether full time or part-time)
without the prior written approval of the CEO. Further, you agree that while you render services to the Company, you will not engage in any other activities that conflict with your obligations to the Company. By signing this letter agreement, you
confirm to the Company that you have no contractual commitments or other legal obligations that would prohibit you from performing your duties for the Company and that you will not bring any third party confidential information to the Company,
including that of your former employer, and that in performing your duties for the Company, you will not in any way utilize or disclose any such information. 

Cash Compensation: The Company will pay you an annual base salary at the rate $310,000 per year (the “Base Salary”) payable in accordance
with the Company’s standard payroll schedule and subject to applicable withholdings. Your Base Salary will be subject to review and adjustment pursuant to the Company’s normal performance review practices and employee compensation policies
as may be in effect from time to time. You should note that the Company may modify job titles, salaries and benefits from time to time as it deems necessary. 

  

					
		  	7068 Koll Center Parkway, Suite 401, Pleasanton, CA 94566	  	

 

 
  

 You will also eligible to participate in the 2018 bonus plan. You will be entitled to receive an annual bonus
for calendar year 2018 less applicable withholdings as follows: You will be entitled to receive a bonus equal to 21% of the amount of your Base Salary earned during the 2018 calendar year if the Company achieves its goals approved by the Board for
2018. Bonuses will be pro-rated for the period of the 2018 during which you work at 10x. Employees must be active 10x employees on the date of payment for any bonus to be earned and paid. Any bonus will be
paid at the discretion of the Board of Directors. The Company reserves the right to amend or withdraw the bonus, at its sole and absolute discretion. 

Stock Option: Subject to the approval of the Company’s Board of Directors, you will be granted an option to purchase 600,000 shares of the
Company’s common stock. The option will be subject to the terms and conditions applicable to options granted under the Company’s 2012 Stock Plan (the “Plan”), as described in that plan and the applicable stock option agreement,
which you will be required to sign. You will vest in 25% of the option shares on the 12-month anniversary of your vesting commencement date and 1/48th of
the total option shares will vest in 36 monthly installments thereafter during your continuous service, as described in the applicable stock option agreement. The option will be subject to your ability to early exercise, subject to the
Company’s right to repurchase those shares (in all events in accordance with the Plan). The exercise price per share will be equal to the fair market value per share on the date the option is granted, as determined by the Company’s Board
of Directors in good faith compliance with applicable guidance in order to avoid having the option treated as deferred compensation under Section 409A of the Internal Revenue Code of 1986, as amended. There is no guarantee that the Internal
Revenue Service will agree with this value. You should consult with your own tax advisor concerning the tax risks associated with accepting an option to purchase the Company’s common stock. 

Employee Benefits: As a regular employee of the Company, you will be eligible to participate in Company-sponsored employee benefit plans currently and
hereafter maintained by the Company 

  

					
		  	7068 Koll Center Parkway, Suite 401, Pleasanton, CA 94566	  	

 

 
  

 
of general applicability to other senior executives of the Company located in the United States; in all cases subject to the terms and conditions of such plans, as in effect from time to time.
The Company may modify benefits at any time and from time to time in its sole discretion. 
 Severance. In the event that the Company terminates your
employment without Cause (as defined below) within the first 12 months of your employment, the Company shall pay you a lump sum amount of five hundred thousand dollars ($500,000) subject to applicable withholdings and subject to your execution
(within 30 days of your termination date) and non-revocation of a release of claims in a form acceptable to the Company. For purposes of this letter agreement, “Cause” shall mean the Company’s
good faith determination that you have (i) committed either a felony or other crime involving moral turpitude or any other act or omission involving theft, dishonesty, disloyalty, or fraud; (ii) substantially and repeatedly failed to
follow the policies, procedures and guidelines of the Company of substantially and repeatedly failed to perform your duties as reasonably directed by the Company; (iii) committed a breach of fiduciary duty, gross negligence, or willful
misconduct with respect to the Company; or (iv) committed any material breach of this agreement. If your employment ends for any reason other than discharge by the Company for Cause, but at a time when the Company had Cause to terminate you (or
would have Cause if it knew all relevant facts), your termination shall be treated as a discharge by the Company for Cause. 
 At-Will Employment Relationship: The Company is excited about your joining and looks forward to a beneficial and productive relationship. Nevertheless, you should be aware that your employment with the Company
is for no specified period and constitutes at-will employment. As a result, you are free to resign at any time, for any reason or for no reason. Similarly, the Company is free to conclude its employment
relationship with you at any time, with or without cause, and with or without notice. We request that, in the event of resignation, you give the Company at least two weeks’ notice. This at-will employment
provision may not be modified or amended except by a written agreement signed by the CEO of the Company and you. 
 Confidentiality: The Company is
offering you employment because of your experience and personal skills, and not due to your potential or actual knowledge of a former employer or other 

  

					
		  	7068 Koll Center Parkway, Suite 401, Pleasanton, CA 94566	  	

 

 
  

 
persons or entity’s confidential information or intellectual property, including customer lists and trade secrets. Should you accept this offer, we do not want you to retain, make use of, of
share any such information with the Company. Likewise, as an employee of the Company, it is likely that you will become knowledgeable about the Company’s confidential and trade secret information relating to operations, products, and services.
To protect the Company’s interests, your acceptance of this offer and commencement of employment with the Company are contingent upon the execution and delivery to the Company of the Company’s
At-Will Employment, Confidential Information, Invention Assignment and Arbitration Agreement (“Confidentiality Agreement”) prior to or on your Start Date. The Confidentiality Agreement, which
provides for the arbitration of all disputes arising out of your employment, is enclosed for your review, and you understand that you are being offered employment in exchange for the mutual promise to arbitrate disputes described therein. Because
the Confidentiality Agreement is one of the most important documents you will sign in connection with your employment with the Company, we trust you will review it carefully and let us know if you have any questions. 

Miscellaneous: The Company reserves the right to conduct background investigations and/or reference checks on all of its potential employees. Your job
offer, therefore, is contingent upon a clearance of such a background investigation and/or reference check, if any. 
 For purposes of federal immigration
law, you will be required to provide to the Company documentary evidence of your identity and eligibility for employment in the United States. Such documentation must be provided to us within three (3) business days of your date of hire, or our
employment relationship with you may be terminated. 
 In addition, please find enclosed a copy of the 10x welcome letter to prospective employees. Read it
carefully and let us know if you have any questions. 
 To accept the Company’s offer, please sign and date this letter in the space provided below. If
you accept our offer, your first day of employment will be September 28, 2018. This letter, along with any agreements relating to proprietary rights between you and the Company, set forth the terms of your employment with the Company and
supersede any prior representations or agreements including, but not limited to, any representations made during your recruitment, interviews, or pre-employment negotiations, whether written or oral. This
offer of employment will terminate if not accepted, signed, and returned by August 20, 2018. 

  

					
		  	7068 Koll Center Parkway, Suite 401, Pleasanton, CA 94566	  	

 

 
  

 We look forward to your favorable reply and to working with you at 10x! 

 

	
	Sincerely,
	
	/s/ Serge Saxonov CEO
	Serge Saxonov CEO

  

	
	Signature:
	
	/s/ Justin McAnear
	Justin McAnear
	
	August 17, 2018
	Date

  

					
		  	7068 Koll Center Parkway, Suite 401, Pleasanton, CA 94566

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00299-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00299-of-00352.parquet"}]]